• New data on Alzstatin for preventive treatment against Alzheimer's presented at Alzheimer's conference CTAD

  • AlzeCure Pharma AB publishes prospectus and invites to investor presentations

  • The subscription period in AlzeCure Pharma AB's rights issue begins today and the CEO has participated in a company presentation and CEO interview with Erik Penser Bank

  • Rights Issue December 2022

AlzeCure Pharma

AlzeCure Pharma is a Swedish pharmaceutical company focusing on the research and development of innovative and efficacious treatments for Alzheimer’s disease and related disorders


AlzeCure is developing disease modifying and symptomatic first in class treatments for Alzheimer’s disease and other conditions characterized by cognitive dysfunction

Alzheimer’s Disease

Alzheimer’s disease is a deadly disorder which lacks effective treatments. The need for novel treatments is therefore urgent.